---
title: "Assessment of clozapine-related immunodeficiency effect in Parkinson's disease patients (CLOZIDPD)"
euct_id: 2024-514530-21-00
status: Not yet recruiting
sponsor: Centre Hospitalier Universitaire Amiens Picardie
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-514530-21-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-514530-21-00"
ctis_last_updated: "2024-08-24T03:00:32.486570667"
source: EU Clinical Trials Information System (CTIS)
---
# Assessment of clozapine-related immunodeficiency effect in Parkinson's disease patients (CLOZIDPD)

**EU CT Number:** [2024-514530-21-00](https://euclinicaltrials.eu/ctis-public/view/2024-514530-21-00)

## Key Facts

- **Status:** Not yet recruiting
- **Sponsor:** Centre Hospitalier Universitaire Amiens Picardie
- **Start Date:** 2024-09-01
- **Completion Date:** 2027-09-01
- **Conditions:** Parkinson's disease
- **Interventions:** CLOZAPINE

## Member States

Trial is authorized in 1 member state: France.

## Sites (1)

- Centre Hospitalier Universitaire Amiens Picardie, Amiens Cedex 1, France

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: adults 18-64, elderly 65+
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-514530-21-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-514530-21-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-514530-21-00*